In light of Republic Act No. 11467, the Consolidated VAT Regulations of 2005 (RR No. 16-2005, as amended by RR No. 13-2018) have been amended to include the VAT-exempt sale or importation of prescription drugs and medicines for:
- Diabetes, high cholesterol and hypertension (beginning 1 January 2020); and
- Cancer, mental illness, tuberculosis and kidney disease (beginning 1 January 2023).
Source PwC
Latest Posts in "Philippines"
- Navigating Output VAT Credit Under the EOPT Act: Key Rules and Remedies for Taxpayers
- Philippine Court Denies VAT Refund for Prescription Drugs Due to Insufficient Proof of Non-Claim
- DOF Denies VAT Hike Rumors, Urges Officials to Stop Spreading Fake News
- DOF Denies VAT Hike, Urges Responsible Reporting Amid Revenue Collection Updates and Reforms
- BIR e-Invoicing Philippines 2026: Scope, Rollout, Compliance, and Technical Requirements Explained
